RVTY · Revvity, Inc.
Market Cap
$14.58B
Shares
111.59M
RVTY metrics
89 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$130.63
Market cap
$14.58B
Price action
19 metricsPrice change (1W)
+0.7%
Price change (30D)
+14.3%
Price change (3M)
+27.6%
Price change (6M)
+35.3%
Price change (YTD)
+35.0%
Price change (1Y)
+56.7%
Trailing year
Price change (5Y)
-31.4%
52-week high
$130.94
52-week low
$82.26
Change from 52-week high
-0.2%
Change from 52-week low
+58.8%
Annualized volatility
37.8%
Beta
1.3
RSI (14D)
68.6
Price vs SMA 50
+12.6%
Price vs SMA 200
+27.9%
Avg volume (3M)
1.50M
Relative volume
1.2
Average dollar volume
$171.17M
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
111.59M
Valuation
12 metricsP / E (TTM)
62.5
Trailing earnings · reciprocal yield 1.6%
PEG ratio
28.8
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
5.0×
reciprocal yield 20.0%
P / book
2.0
reciprocal yield 49.6%
FCF yield
3.8%
TTM · current market cap
Buyback yield
3.3%
P / FCF
26.1
reciprocal yield 3.8%
P / operating cash flow
23.2
reciprocal yield 4.3%
Earnings yield
1.6%
Historical valuation
8 metricsP / E historical average (3Y)
42.5×
reciprocal yield 2.4%
P / E historical average (5Y)
34.9×
reciprocal yield 2.9%
EV / revenue historical average (3Y)
5.4×
reciprocal yield 18.6%
EV / revenue historical average (5Y)
5.2×
reciprocal yield 19.4%
EV / EBIT historical average (3Y)
37.9×
reciprocal yield 2.6%
EV / EBIT historical average (5Y)
32.8×
reciprocal yield 3.0%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
0.2%
Trailing 12 months
Payout ratio
13.4%
Shareholder yield
3.5%
Dividend / share (TTM)
$0.28
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-07-17
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-04
Profitability
9 metricsGross margin
—
Operating margin
12.3%
Trailing 12 months
Net margin
8.2%
Gross profit (TTM)
$1.99B
Operating profit (TTM)
$358.85M
Net income (TTM)
$237.55M
Trailing 12 months
Diluted EPS (TTM)
$2.09
FCF margin
19.2%
Effective tax rate
9.0%
Growth
11 metricsRevenue growth YoY
+1.3%
Year over year
Net income growth YoY
-3.9%
Revenue (TTM)
$2.91B
Trailing 12 months
EPS growth YoY
+2.2%
Shares change YoY
-5.0%
Year over year · fewer shares
Revenue CAGR (3Y)
-4.8%
Revenue CAGR (5Y)
-5.5%
EPS CAGR (3Y)
-22.8%
EPS CAGR (5Y)
-20.4%
FCF CAGR (3Y)
-5.0%
FCF CAGR (5Y)
-9.3%
Quality
14 metricsReturn on equity
3.3%
Return on assets
2.0%
Debt / equity
0.4
Current ratio
1.8
EBITDA (TTM)
$771.08M
Free cash flow (TTM)
$558.11M
Quick ratio
1.5
Interest coverage
3.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.02B
Total assets
$12.05B
Total debt
$3.21B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$627.63M
Capital expenditures (TTM)
$69.52M
R&D (TTM)
$215.83M
SG&A (TTM)
$1.03B
Stock compensation (TTM)
—
R&D / revenue
7.4%
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
544
13F filer change QoQ
+37
Institutional ownership
102.2%
Short interest
3 metricsShort interest
5.7%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
65 / 100
Insider activity
2 metricsNet insider buying (90D)
−$9,306
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
31791
CUSIP
714046109
13F (30d)
339 filings
319 filers
Visit website
Investor relations